| Tuesday, April 01, 2003 |
| 12:00:00 PM |
James Hodge |
Bldg 549 Conf. Rm B |
| |
|
Details
|
|
| 12:00:00 PM |
James Hodge |
Bldg 549 Conf. Rm B |
| |
Combination Vaccine and Radiation Therapy for Established Tumors
|
Details
Series
|
|
| 4:00:00 PM |
Jay Shapiro (NASA) and Pamela Robey |
Bldg 549 Auditorium |
| |
Space, Mars and Bones
|
Details
Series
|
|
| 4:00:00 PM |
Phil Taylor, MD |
Bldg 10, 2S235 |
| |
Prevention Studies
|
Details
Series
|
| Wednesday, April 02, 2003 |
| 8:30:00 AM |
Dr. Jeffrey Arbeit |
Bldg 549 Auditorium |
| |
Probing HIF-Lalpha Biology and structure-Function in Epithelium of Transgenic Mice
|
Details
|
|
| 12:00:00 PM |
Dr. Mourad Majidi |
Bldg 539 Library |
| |
C-Kit Expression Profile in Gastrointestinal Stromal Tumors (GIST)
|
Details
|
|
| 12:00:00 PM |
Mike Turell |
Bldg 549 Auditorium |
| |
Mosquito Vectors of Emerging Diseases: West Nile in the US and Field Studies in the Amazon Basin Region of Peru
|
Details
Series
|
|
| 4:00:00 PM |
Susan Bates, M.D., Cancer Therapeutics Branch |
Bldg 549 Auditorium |
| |
The Role of Depsipeptide, a Histone Deacetylase Inhibitor in the Treatment of T Cell "Lymphoma"
|
Details
Series
|
| Monday, April 07, 2003 |
| 2:00:00 PM |
Gaoxing Luo, M.D., Ph.D. |
Bldg 549 Conf. Rm B |
| |
Administration of Ad-CTLA4Ig Locally to Prolong the Survival Time of Xenoskin Graft on Burn wound
|
Details
|
| Tuesday, April 08, 2003 |
| 12:00:00 PM |
Richard Hodes |
Bldg 10, 2S235 |
| |
TBA
|
Details
Series
|
|
| 12:00:00 PM |
Richard Hodes |
Bldg 549 Conf. Rm B |
| |
|
Details
|
|
| 2:00:00 PM |
Emily Boja |
Bldg 549 Auditorium |
| |
Structural Characterization and Post-Translational Processing of Mouse Zona Pellucida Glycoproteins Using Mass Spectrometry
|
Details
Series
|
|
| 4:00:00 PM |
Juan Bonaficino & Bill Gahl |
Bldg 549 Auditorium |
| |
Lysosomes: Biology and Diseases
|
Details
Series
|
| Wednesday, April 09, 2003 |
| 12:00:00 PM |
Bob Wiltrout |
Bldg 549 Auditorium |
| |
Coordination of Innate and Adaptive Anti-tumor Immune Responses by IL-12, IL-2, and Stimulation Through CD40
|
Details
Series
|
|
| 3:30:00 PM |
Ms. M.J. Tooey, MLS,AHIP |
Bldg 549 Auditorium |
| |
Desk Set
|
Details
|
| Thursday, April 10, 2003 |
| 8:30:00 AM |
Dr. Peter Cooper |
Bldg 549 Auditorium |
| |
A Field Guide to Genbank and NCBI Molecular Biology Resources
|
Details
|
| Friday, April 11, 2003 |
| 8:15:00 AM |
Dr. Ed Sausville, Dr. T.C.Chou, Dr. W.R. Greco, Dr. J. Weinstein, Dr. V.I. Avramis, Dr. P.A. Burke, Dr. S. Grant, Dr. J. Sebolt-Leopold, Dr. N. Saijo |
Bldg 549 Auditorium |
| |
Preclinical Models for Defining Efficacy of Drug Combinations: Mapping the Road to the Clinic
|
Details
|
|
| 12:00:00 PM |
Dr. Paul J. Leibson |
Bldg 426 Conf. Rm |
| |
Regulation of Cytotoxic Lymphocyte Activation
|
Details
|
| Monday, April 14, 2003 |
| 8:30:00 AM |
James Watson & Francis Collins |
Bldg 45 Natcher, Main Aud |
| |
From Double Helix to Human Sequence - and Beyond
|
Details
|
|
| 2:00:00 PM |
Todd Pearson, Ph.D. |
Bldg 549 Conf. Rm B |
| |
The Genetic Basis of Resistance to Transplantation Tolerance Induced By Costimulation Blockade in NOD Mice
|
Details
|
| Tuesday, April 15, 2003 |
| 8:30:00 AM |
James Watson & Francis Collins |
Bldg 45 Natcher, Main Aud |
| |
From Double Helix to Human Sequence - and Beyond
|
Details
|
|
| 11:00:00 AM |
Daniela Rotin, PhD |
Bldg 549 Auditorium |
| |
Structure and Function of the Ubiquitin Ligase Nedd4
|
Details
|
|
| 12:00:00 PM |
Suzanne Topalian |
Bldg 10, 2S235 |
| |
Evaluation of Novel Cancer Antigens for Clinical Immunotherapeutic Applications
|
Details
Series
|
|
| 12:00:00 PM |
|
Bldg 549 Executive Board Room |
| |
Institutional Biosafety Committee
|
Details
|
|
| 12:00:00 PM |
Suzanne Topalian |
Bldg 549 Conf. Rm B |
| |
|
Details
Series
|
|
| 12:30:00 PM |
Dr. John Petrini |
Bldg 549 Conf. Rm A |
| |
Genetics and Cellular Analysis of the Cellular DNA Damage Response
|
Details
Series
|
| Wednesday, April 16, 2003 |
| 9:00:00 AM |
Heinz G. Floss, MD |
Bldg 549 Auditorium |
| |
Genetic Tools for the Biosynthetic Structure Modification of the Maytansinoid Antitumor Agents
|
Details
Series
|
|
| 12:00:00 PM |
Andy Byrd--CANCELLED |
Bldg 549 Auditorium |
| |
Structural Biology in Signal Transduction: The Jak/Stat and HGF Pathways
|
Details
Series
|
|
| 1:15:00 PM |
Stephen Hecht |
Bldg 549 Auditorium |
| |
Cigarette Smoking and Lung Cancer: Chemical Mechanisms and Approaches to Prevention
|
Details
Series
|
| Thursday, April 17, 2003 |
| 11:00:00 AM |
Terumi Kohwi-Shigematsu, PhD |
Bldg 40 Conf. Room 1201/1203 |
| |
Tissue-specific Nuclear Architecture and Gene Function Regulated by a Single Protein SATB1
|
Details
Series
|
|
| 4:00:00 PM |
Jennifer Lippincott-Schwartz & Win Arias |
Bldg 549 Conf. Rm B |
| |
ABC Transporter Diseases and Intracellular Trafficking
|
Details
Series
|
| Friday, April 18, 2003 |
| 12:00:00 PM |
Klaus Ley, M.D. |
Bldg 426 Conf. Rm |
| |
Arrest Chemokines
|
Details
|
|
| 12:15:00 PM |
John M. Parant |
Bldg 539 Library |
| |
Genetic Analysis of mdm2.mdm4 and p53.
|
Details
|
| Monday, April 21, 2003 |
| 9:30:00 AM |
Dr. Heiner Fiebig |
Bldg 549 Auditorium |
| |
In Vivo Models for Cancer Drug Development: The Freiburg Approach
|
Details
|
|
| 2:00:00 PM |
Illya Tietzel, Ph.D. |
Bldg 549 Conf. Rm B |
| |
Mechanisms of Co-Stimulatory IL-10 Induction by Fcgamma Receptor Cross-Linking
|
Details
|
| Tuesday, April 22, 2003 |
| 12:00:00 PM |
Remy Bosselut |
Bldg 10, 2S235 |
| |
Dissecting Intrathymic T-lymphocyte Selection Through the Use of Stage-Specific Transgenic Expression Vectors
|
Details
Series
|
|
| 12:00:00 PM |
Remy Bosselut |
Bldg 549 Conf. Rm B |
| |
|
Details
|
|
| 4:00:00 PM |
Michael Gottesman & Susan Bates |
Bldg 549 Conf. Rm B |
| |
Multidrug Resistance in Cancer
|
Details
Series
|
| Wednesday, April 23, 2003 |
| 10:00:00 AM |
Dr. Dale Bredesen |
Bldg 549 Auditorium |
| |
II b or Not II b? The Many Programs of Cell Death
|
Details
|
|
| 12:00:00 PM |
Mark Fortini |
Bldg 549 Auditorium |
| |
Proteolytic Regulation of Notch Receptor Signaling
|
Details
Series
|
| Thursday, April 24, 2003 |
| 1:00:00 PM |
Dr. George Mitra; Dr. Christopher W. Kemp; Dr. Hua Jiang; Dr. Chia-li Liu; Dr. Jinyou Zhang |
Bldg 549 Auditorium |
| |
Microbial/Cell Culture Process Development
|
Details
|
| Friday, April 25, 2003 |
| 12:00:00 PM |
Dr. Barry Rouse |
Bldg 426 Conf. Rm |
| |
Immunoinflammatory Events in Herpetic Eye Lesions
|
Details
|
|
| 3:00:00 PM |
Dr. Randy L. Jirtle |
Bldg 549 Auditorium |
| |
Evolution of Imprinted Cancer Susceptibility Genes
|
Details
Series
|
| Tuesday, April 29, 2003 |
| 12:00:00 PM |
Maria Parkhurst |
Bldg 10, 2S235 |
| |
The Development of Novel Immunotherapies for Solid Tumors Based on the Identification of Tumor-Associated Antigens
|
Details
Series
|
|
| 4:00:00 PM |
|
Bldg 549 Auditorium |
| |
Immunotherapy in Cancer
|
Details
Series
|
| Wednesday, April 30, 2003 |
| 9:00:00 AM |
Dr. Alan Eastman |
Bldg 549 Auditorium |
| |
Cell Cycle Checkpoint Inhibitors in Cancer Therapy
|
Details
|
|
| 12:00:00 PM |
Jim Kelley |
Bldg 549 Auditorium |
| |
New Life for an "Old" Compound. Preclinical Studies on the Development of Zebularine as an Orally Active Inhibitor of DNA Methyl Transferase
|
Details
Series
|
